Tag Archives: Clinical

Soligenix Inc (OTCBB:SNGX) Completes Enrollment Into Phase II Clinical Trial … – StocksnTrade (registration) (blog)

StocksnTrade (registration) (blog) Soligenix Inc (OTCBB:SNGX) Completes Enrollment Into Phase II Clinical Trial …StocksnTrade (registration) (blog)A couple of weeks ago, Soligenix Inc (OTCBB:SNGX) reported that it completed patient enrollment as suggested by the Data Review Committee earlier in 2015, into … Continue reading

Posted in OTCBB | Tagged , , , , , , , , , , | Comments Off on Soligenix Inc (OTCBB:SNGX) Completes Enrollment Into Phase II Clinical Trial … – StocksnTrade (registration) (blog)

Burzynski Research Institute, Inc. Announces FDA Permission to Launch a New Clinical Trial in Diffuse Intrinsic …

HOUSTON, Oct. 24, 2014 /PRNewswire/ — Burzynski Research Institute, Inc. (BRI) announced today that the U.S. Food and Drug Administration (FDA) has given the company permission to conduct an open-label study of Antineoplastons A10 and AS2-1 in patients > 3 … Continue reading

Posted in OTCBB | Tagged , , , , , , , , , , | Comments Off on Burzynski Research Institute, Inc. Announces FDA Permission to Launch a New Clinical Trial in Diffuse Intrinsic …

Medical Technology Breaking News Aethlon Medical (OTCQB AEMD) Note U.S. Clinical Progression

(MENAFN – InvestorIdea) Category: Investment, Biotech, Biodefense Medical Technology Breaking News: Aethlon Medical (OTCQB: AEMD) Note: U.S. Clinical Progression Visit this com… OTCBB from Google and yahoo

Posted in OTCBB | Tagged , , , , , , , , , , | Comments Off on Medical Technology Breaking News Aethlon Medical (OTCQB AEMD) Note U.S. Clinical Progression

Nutranomics releases results of human patient clinical studies regarding Glucozyme

Nutranomics, Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company") is pleased to announce that the results of human patient clinical studies undertaken by the Company regarding Glucozyme™ are nearing a public release date. OTCBB from Google and yahoo

Posted in OTCBB | Tagged , , , , , , , , | Comments Off on Nutranomics releases results of human patient clinical studies regarding Glucozyme

Nurse Call & Clinical Workflow Solutions Provider, Azure Healthcare reports continued revenue growth for half year 2012/13.

Melbourne, Victoria (PRWEB) March 05, 2013 Azure Healthcare Limited (ASX:AZV) has made dramatic progress over the past twelve months by refocusing the companys existing business to match the core strengths. Focusing on the core Healthcare business and building a strong … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , | Comments Off on Nurse Call & Clinical Workflow Solutions Provider, Azure Healthcare reports continued revenue growth for half year 2012/13.

Dental Clinical Instrument Manufacturing in the US Industry Market Research Report Now Available from IBISWorld

Los Angeles, CA (PRWEB) August 20, 2012 Over the past five years, the Dental Clinical Instrument Manufacturing industry has been growing steadily. IBISWorld expects industry revenue to grow at an annualized rate of 4.7% to about $ 1.2 billion over … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , | Comments Off on Dental Clinical Instrument Manufacturing in the US Industry Market Research Report Now Available from IBISWorld

QualityStocks News – Access Pharmaceuticals Presents Positive Data of MuGard Phase 4 Clinical Trial at Cancer Symposium

Scottsdale, AZ (PRWEB) June 29, 2012 QualityStocks would like to highlight Access Pharmaceuticals, Inc., a publicly traded biopharmaceutical company that develops and commercializes proprietary products for the treatment and supportive care of cancer patients. The company’s products include MuGard, which … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , , | Comments Off on QualityStocks News – Access Pharmaceuticals Presents Positive Data of MuGard Phase 4 Clinical Trial at Cancer Symposium

QualityStocks News – Northwest Biotherapeutics Receives $5.5M Grant to Cover Manufacturing and Clinical Trial Costs

Scottsdale, Arizona (PRWEB) May 02, 2012 QualityStocks would like to highlight Northwest Biotherapeutics, Inc., a publicly traded biotechnology company focused on developing immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , | Comments Off on QualityStocks News – Northwest Biotherapeutics Receives $5.5M Grant to Cover Manufacturing and Clinical Trial Costs

Elsevier Launches ClinicalKey, a Breakthrough Clinical Insight Engine, Bringing Fast, Trusted and Comprehensive Medical Content to Clinicians

Sydney, New South Wales (PRWEB) April 18, 2012 Elsevier, a world-leading provider of medical content and solutions, today announced ClinicalKey, the next generation of online clinical information resources. ClinicalKey draws answers from the largest collection of clinical resources, covering every … Continue reading

Posted in Stock Market Investing | Tagged , , , , , , , , , , , , , | Comments Off on Elsevier Launches ClinicalKey, a Breakthrough Clinical Insight Engine, Bringing Fast, Trusted and Comprehensive Medical Content to Clinicians

Proteonomix provides corporate and clinical trial updates

Proteonomix, Inc., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today provided updates on its progress. OTCBB from Google and yahoo

Posted in OTCBB | Tagged , , , , , | Comments Off on Proteonomix provides corporate and clinical trial updates

Metro

Metro® Introduces Enhanced Service Program at ASHP Midyear Clinical meeting & Exhibition Metro ESP WILKES-BARRE, Pa. (PRWEB) December 06, 2011 Metro®, a world leader in … Continue reading

Posted in Investing | Tagged , , , , , , , , , | Comments Off on Metro